Dabrafenib Mesylate and Sodium Polystyrene Sulfonate Suspension
Determining the interaction of Dabrafenib Mesylate and Sodium Polystyrene Sulfonate Suspension and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabrafenib
Brand name: Tafinlar
Synonyms: Dabrafenib
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabrafenib Mesylate-Sodium Sulf/Potassium Sulf/Mag Sulf/Polyethylene Glycol-Electrolyte Soln
- Dabrafenib Mesylate-Sodium Sulfacetamide and Sulfur Aqueous Gel
- Dabrafenib Mesylate-Sodium Sulfacetamide and Sulfur Cleanser
- Dabrafenib Mesylate-Sodium Sulfacetamide and Sulfur Cream
- Dabrafenib Mesylate-Sodium Sulfacetamide and Sulfur Foam
- Dabrafenib Mesylate-Sodium Sulfacetamide and Sulfur Lotion
- Sodium Polystyrene Sulfonate Suspension-Dacarbazine
- Sodium Polystyrene Sulfonate Suspension-Dacarbazine Intravenous, Injection
- Sodium Polystyrene Sulfonate Suspension-Daclatasvir
- Sodium Polystyrene Sulfonate Suspension-Daclatasvir Dihydrochloride
- Sodium Polystyrene Sulfonate Suspension-Daclizumab
- Sodium Polystyrene Sulfonate Suspension-Daclizumab Subcutaneous